These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 8081537)

  • 1. The Flutter VRP1: a new personal pocket therapeutic device used as an adjunct to drug therapy in the management of bronchial asthma.
    Girard JP; Terki N
    J Investig Allergol Clin Immunol; 1994; 4(1):23-7. PubMed ID: 8081537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of flutter VRP1 in the management of patients with steroid-dependent asthma.
    Swift GL; Rainer T; Saran R; Campbell IA; Prescott RJ
    Respiration; 1994; 61(3):126-9. PubMed ID: 8047714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy of the FLUTTER VRP1 device for physiotherapy patients with chronic pulmonary disease].
    Lubiński W; Targowski T; Frank-Piskorska A
    Pol Merkur Lekarski; 2000 Jan; 7(43):37-40. PubMed ID: 10765651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flutter-VRP1 Desitin--a new physiotherapeutic device for the treatment of chronic obstructive bronchitis.
    Leru P; Bistriceanu G; Ibraim E; Stoicescu P
    Rom J Intern Med; 1994; 32(4):315-20. PubMed ID: 7613505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of bronchial obstruction with bi-level positive airway pressure and nebulization in patients with acute asthma.
    Brandao DC; Lima VM; Filho VG; Silva TS; Campos TF; Dean E; de Andrade AD
    J Asthma; 2009 May; 46(4):356-61. PubMed ID: 19484669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physiotherapy in chronic obstructive pulmonary disease: oscillatory breathing with flutter VRP1].
    Weiner P; Zamir D; Waizman J; Weiner M
    Harefuah; 1996 Jul; 131(1-2):14-7, 71. PubMed ID: 8854470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of Flutter®VRP1 components on mucus transport of patients with bronchiectasis.
    Tambascio J; de Souza LT; Lisboa RM; Passarelli Rde C; de Souza HC; Gastaldi AC
    Respir Med; 2011 Sep; 105(9):1316-21. PubMed ID: 21641196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of a positive expiratory pressure device in conjunction with beta2-agonist nebulization therapy for bronchial asthma.
    Tsai CF; Tsai JJ
    J Microbiol Immunol Infect; 2001 Jun; 34(2):92-6. PubMed ID: 11456366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of flutter and PEP mask physiotherapy on symptoms and lung function in children with cystic fibrosis.
    van Winden CM; Visser A; Hop W; Sterk PJ; Beckers S; de Jongste JC
    Eur Respir J; 1998 Jul; 12(1):143-7. PubMed ID: 9701429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acute effect of use of the Flutter on expectoration of sputum in patients with chronic respiratory diseases].
    Nakamura S; Kawakami M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Feb; 34(2):180-5. PubMed ID: 8622274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective randomized controlled trial on the efficacy of noninvasive ventilation in severe acute asthma.
    Gupta D; Nath A; Agarwal R; Behera D
    Respir Care; 2010 May; 55(5):536-43. PubMed ID: 20420722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The use of a respiratory regulator in the combined therapy of obstructive lung diseases].
    Aleksandrov OV; Struchkov PV; Fedechkin VV; Vinitskaia RS; Leont'ev AV; Liukevich IA; Dorokhova NS
    Ter Arkh; 1990; 62(1):73-5. PubMed ID: 2333624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the effect of yoga training on pulmonary functions in patients with bronchial asthma.
    Sodhi C; Singh S; Dandona PK
    Indian J Physiol Pharmacol; 2009; 53(2):169-74. PubMed ID: 20112821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance analysis of the Flutter VRP1 under different flows and angles.
    Alves LA; Pitta F; Brunetto AF
    Respir Care; 2008 Mar; 53(3):316-23. PubMed ID: 18291047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanical behaviors of Flutter VRP1, Shaker, and Acapella devices.
    dos Santos AP; Guimarães RC; de Carvalho EM; Gastaldi AC
    Respir Care; 2013 Feb; 58(2):298-304. PubMed ID: 22906833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peak inspiratory flow and inspiratory vital capacity of patients with asthma measured with and without a new dry-powder inhaler device (Turbuhaler).
    Engel T; Heinig JH; Madsen F; Nikander K
    Eur Respir J; 1990 Oct; 3(9):1037-41. PubMed ID: 2289551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of ventilation parameters before and after fiber optic bronchoscopy in patients with atopic bronchial asthma and chronic obstructive pulmonary diseases].
    Bajera I; Maleszka P; From S
    Pol Merkur Lekarski; 1997 Oct; 3(16):171-3. PubMed ID: 9461723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physical therapy in patients with COPD and tracheobronchial instability--comparison of 2 oscillating PEP systems (RC-Cornet, VRP1 Desitin). Results of a randommized prospective study of 90 patients].
    Cegla UH; Bautz M; Fröde G; Werner T
    Pneumologie; 1997 Feb; 51(2):129-36. PubMed ID: 9157451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Physical therapy with VRP1 in chronic obstructive respiratory tract diseases--results of a multicenter comparative study].
    Cegla UH; Retzow A
    Pneumologie; 1993 Nov; 47(11):636-9. PubMed ID: 8309924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A study on peak expiratory flow monitoring maneuver as compared to forced expiratory flow maneuver].
    Nagasaka Y; Fujita E; Hazu R; Nishimura N; Nakajima S
    Arerugi; 1996 Jan; 45(1):34-40. PubMed ID: 8851314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.